HSA
EDIT icon

Hussman Strategic Advisors’s Editas Medicine EDIT Stock Holding History

Hussman Strategic Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-31,000
Closed -$225K – 306
2023
Q1 		$225K Hold
31,000
– – 0.04% 293
2022
Q4 		$275K Buy
31,000
+20,600
+198% +$226K 0.04% 276
2022
Q3 		$127K Hold
10,400
– – 0.02% 277
2022
Q2 		$123K Hold
10,400
– – 0.02% 295
2022
Q1 		$198K Hold
10,400
– – 0.04% 292
2021
Q4 		$276K Sell
10,400
-8,200
-44% -$282K 0.06% 284
2021
Q3 		$764K Sell
18,600
-12,400
-40% -$679K 0.17% 190
2021
Q2 		$1.76M Buy
31,000
+16,600
+115% +$613K 0.36% 106
2021
Q1 		$605K Sell
14,400
-16,350
-53% -$931K 0.12% 238
2020
Q4 		$2.16M Sell
30,750
-45,750
-60% -$1.88M 0.57% 62
2020
Q3 		$2.15M Sell
76,500
-25,500
-25% -$831K 0.57% 56
2020
Q2 		$3.02M Sell
102,000
-500
-0.5% -$13.1K 0.77% 15
2020
Q1 		$2.03M Buy
102,500
+36,000
+54% +$908K 0.55% 54
2019
Q4 		$1.97M Buy
+66,500
New +$1.66M 0.63% 57

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Hussman Strategic Advisors's EDIT Position: Q2 2023 in Review

Hussman Strategic Advisors sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 31,000 shares — an estimated $225K sold.

Hussman Strategic Advisors first reported a position in EDIT in Q4 2019 and held it in 14 quarters. The position peaked at $3.02M in Q2 2020. 237 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

  • Hussman Strategic Advisors reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
  • Hussman Strategic Advisors sold 31,000 Editas Medicine shares in Q2 2023, an estimated $225K.
  • Hussman Strategic Advisors first reported a position in Editas Medicine in Q4 2019 and held it in 14 quarters.
  • Hussman Strategic Advisors's Editas Medicine position peaked at $3.02M in Q2 2020.
  • 237 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Hussman Strategic Advisors's 13F filing for Q2 2023, filed 3 Aug 2023.